301 related articles for article (PubMed ID: 34373320)
1. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.
Geurts MH; de Poel E; Pleguezuelos-Manzano C; Oka R; Carrillo L; Andersson-Rolf A; Boretto M; Brunsveld JE; van Boxtel R; Beekman JM; Clevers H
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34373320
[TBL] [Abstract][Full Text] [Related]
2. Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.
Bulcaen M; Kortleven P; Liu RB; Maule G; Dreano E; Kelly M; Ensinck MM; Thierie S; Smits M; Ciciani M; Hatton A; Chevalier B; Ramalho AS; Casadevall I Solvas X; Debyser Z; Vermeulen F; Gijsbers R; Sermet-Gaudelus I; Cereseto A; Carlon MS
Cell Rep Med; 2024 May; 5(5):101544. PubMed ID: 38697102
[TBL] [Abstract][Full Text] [Related]
3. P.F508del editing in cells from cystic fibrosis patients.
Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
[TBL] [Abstract][Full Text] [Related]
4. Prime editing for functional repair in patient-derived disease models.
Schene IF; Joore IP; Oka R; Mokry M; van Vugt AHM; van Boxtel R; van der Doef HPJ; van der Laan LJW; Verstegen MMA; van Hasselt PM; Nieuwenhuis EES; Fuchs SA
Nat Commun; 2020 Oct; 11(1):5352. PubMed ID: 33097693
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation.
Santos L; Mention K; Cavusoglu-Doran K; Sanz DJ; Bacalhau M; Lopes-Pacheco M; Harrison PT; Farinha CM
J Cyst Fibros; 2022 Jan; 21(1):181-187. PubMed ID: 34103250
[TBL] [Abstract][Full Text] [Related]
6. Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells.
Li C; Liu Z; Anderson J; Liu Z; Tang L; Li Y; Peng N; Chen J; Liu X; Fu L; Townes TM; Rowe SM; Bedwell DM; Guimbellot J; Zhao R
PLoS One; 2023; 18(11):e0295009. PubMed ID: 38019847
[TBL] [Abstract][Full Text] [Related]
7. In vivo editing of lung stem cells for durable gene correction in mice.
Sun Y; Chatterjee S; Lian X; Traylor Z; Sattiraju SR; Xiao Y; Dilliard SA; Sung YC; Kim M; Lee SM; Moore S; Wang X; Zhang D; Wu S; Basak P; Wang J; Liu J; Mann RJ; LePage DF; Jiang W; Abid S; Hennig M; Martinez A; Wustman BA; Lockhart DJ; Jain R; Conlon RA; Drumm ML; Hodges CA; Siegwart DJ
Science; 2024 Jun; 384(6701):1196-1202. PubMed ID: 38870301
[TBL] [Abstract][Full Text] [Related]
8. Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor.
Amistadi S; Maule G; Ciciani M; Ensinck MM; De Keersmaecker L; Ramalho AS; Guidone D; Buccirossi M; Galietta LJV; Carlon MS; Cereseto A
Mol Ther; 2023 Jun; 31(6):1647-1660. PubMed ID: 36895161
[TBL] [Abstract][Full Text] [Related]
9.
Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
[TBL] [Abstract][Full Text] [Related]
10. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.
Schwank G; Koo BK; Sasselli V; Dekkers JF; Heo I; Demircan T; Sasaki N; Boymans S; Cuppen E; van der Ent CK; Nieuwenhuis EE; Beekman JM; Clevers H
Cell Stem Cell; 2013 Dec; 13(6):653-8. PubMed ID: 24315439
[TBL] [Abstract][Full Text] [Related]
11. Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.
Maule G; Casini A; Montagna C; Ramalho AS; De Boeck K; Debyser Z; Carlon MS; Petris G; Cereseto A
Nat Commun; 2019 Aug; 10(1):3556. PubMed ID: 31391465
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank.
Geurts MH; de Poel E; Amatngalim GD; Oka R; Meijers FM; Kruisselbrink E; van Mourik P; Berkers G; de Winter-de Groot KM; Michel S; Muilwijk D; Aalbers BL; Mullenders J; Boj SF; Suen SWF; Brunsveld JE; Janssens HM; Mall MA; Graeber SY; van Boxtel R; van der Ent CK; Beekman JM; Clevers H
Cell Stem Cell; 2020 Apr; 26(4):503-510.e7. PubMed ID: 32084388
[TBL] [Abstract][Full Text] [Related]
13. Rewriting CFTR to cure cystic fibrosis.
Maule G; Ensinck M; Bulcaen M; Carlon MS
Prog Mol Biol Transl Sci; 2021; 182():185-224. PubMed ID: 34175042
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing.
Maule G; Arosio D; Cereseto A
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486152
[TBL] [Abstract][Full Text] [Related]
15. Expansion of the prime editing modality with Cas9 from Francisella novicida.
Oh Y; Lee WJ; Hur JK; Song WJ; Lee Y; Kim H; Gwon LW; Kim YH; Park YH; Kim CH; Lim KS; Song BS; Huh JW; Kim SU; Jun BH; Jung C; Lee SH
Genome Biol; 2022 Apr; 23(1):92. PubMed ID: 35410288
[TBL] [Abstract][Full Text] [Related]
16. CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells.
Bellec J; Bacchetta M; Losa D; Anegon I; Chanson M; Nguyen TH
Curr Gene Ther; 2015; 15(5):447-59. PubMed ID: 26264708
[TBL] [Abstract][Full Text] [Related]
17. Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line.
Nguyen T; Aida T; Iijima-Yamashita Y; Tamai M; Nagamachi A; Kagami K; Komatsu C; Kasai S; Akahane K; Goi K; Inaba T; Sanada M; Inukai T
Cancer Sci; 2024 Jun; 115(6):1924-1935. PubMed ID: 38549229
[TBL] [Abstract][Full Text] [Related]
18. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing.
Artegiani B; Hendriks D; Beumer J; Kok R; Zheng X; Joore I; Chuva de Sousa Lopes S; van Zon J; Tans S; Clevers H
Nat Cell Biol; 2020 Mar; 22(3):321-331. PubMed ID: 32123335
[TBL] [Abstract][Full Text] [Related]
19. Introduction of mutations in plants with prime editing.
Hao L; Pu X; Song J
Methods; 2021 Oct; 194():83-93. PubMed ID: 33774158
[TBL] [Abstract][Full Text] [Related]
20. Prime Editing: An Emerging Tool in Cancer Treatment.
Sen D; Sarkar S; Mukhopadhyay P
Mol Biotechnol; 2023 Apr; 65(4):509-520. PubMed ID: 36251123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
